Gastroenterology: NTC submits marketing authorisation application for KLEERKOL® in EU
NTC Srl, R&D driven pharmaceutical company with headquarters in Italy announces the submission of the marketing authorisation application through the European Decentralised Procedure (DCP) for its development product NTC015 (Kleerkol®) for bowel preparation for colonoscopy. “Colonoscopy remains the standard for diagnosing and monitoring colorectal cancer and for diagnosis and surveillance of inflammatory bowel disease”,…